In Q4'25, SG&A Expenses for DPZ reached $142.34M, marking a significant seasonal increase from the prior quarter's $105.09M, while R&D Expenses remained at no data across all periods. This latest data point reflects the highest quarterly SG&A figure in the observed timeframe, underscoring its dominance in the company's operating expenses structure. From Q1'23 to Q4'25, SG&A Expenses exhibited a stable quarterly range of approximately $95M to $115M, with notable spikes to $144.37M in Q4'23 and $138.53M in Q4'24, indicating a consistent pattern of year-end escalation likely tied to fiscal closing activities. R&D Expenses showed no data throughout the period, resulting in a stacked bar chart dominated entirely by SG&A, with overall operating expenses demonstrating low volatility outside of seasonal peaks and no evident long-term growth or decline trend.